FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and constitutes recombinant viral vectors including and expressing antigens of avian pathogens, compositions including the recombinant viral vectors, vaccines including the recombinant viral vectors. Also proposed in the invention are methods for vaccination against various avian pathogens and a method for producing the recombinant viral vectors.
EFFECT: invention provides a possibility of effectively using viral vectors for vaccination.
26 cl, 24 dwg, 13 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
MATERIALS AND METHODS USED FOR TREATMENT OF RESPIRATORY DISEASES IN DOGS | 2020 |
|
RU2811752C2 |
COMPOSITIONS AND METHODS FOR DEGRADATION OF IMPROPERLY PACKAGED PROTEINS | 2016 |
|
RU2761564C2 |
INFLUENZA VIRUS CAPABLE OF INFECTING CANINES AND ITS USE | 2020 |
|
RU2802222C2 |
DNA ANTIBODY CONSTRUCTIONS FOR USE AGAINST LYME DISEASE | 2017 |
|
RU2813829C2 |
GENE THERAPY FOR THE TREATMENT OF HEMOPHILIA A | 2017 |
|
RU2762257C2 |
AAV VECTORS AIMED AT THE CENTRAL NERVOUS SYSTEM | 2015 |
|
RU2727015C2 |
HYBRID PROTEINS OF sPD-1-Fc VARIANT | 2019 |
|
RU2785993C2 |
COMPOSITIONS AND METHODS OF GENE EDITING | 2019 |
|
RU2804665C2 |
INFLUENZA HEMAGGLUTININ COMPOSITIONS WITH HETEROLOGOUS EPITOPES AND/OR ALTERED CLEAVAGE SITES DURING MATURATION | 2017 |
|
RU2769406C2 |
COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN EXPRESSION | 2017 |
|
RU2795467C2 |
Authors
Dates
2021-12-13—Published
2017-10-20—Filed